You are now viewing 21 - 30 of 156 results
May 1, 2009 | Journal Article
With the entry of generic drugs that reduce market share for top-selling brand-name drugs, many pharmaceutical manufacturers are reformulating existing products in an attempt to extend those products' life cycles.
May 1, 2009 | Journal Article
The introduction of a more readable prescription medication label by a pharmacy chain had little effect on medication adherence among chronically-ill patients.
April 21, 2009 | Journal Article
This article examines whether providing a drug facts box on direct-to-consumer advertising can impact consumer understanding and decision-making.
January 1, 2001 | Program Result Report
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.
January 1, 1997 | Program Result Report
From 1992 to 1995, researchers at Harvard Medical School collected a comprehensive cross-section of data on state Medicaid pharmaceutical programs and various models of cost-containment. They also investigated the impacts of five cost-containment methods.
March 6, 2008 | Program Result Report
Researchers at Brandeis University used data from two state-run prescription drug programs for low-income seniors to examine how differences in prescription drug coverage affect enrollment, drug use and spending in state programs.
July 31, 2008 | Program Result Report
Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. Louis F. Rossiter, PhD, and other researchers examined how pharmacogenomics fits within the current health care market.
December 1, 2007 | Program Result Report
The Manhattan Institute for Policy Research released a white paper with recommendations on how to reform the pipeline for new medications, including the approval process by the Food and Drug Administration (FDA).
December 9, 2005 | Program Result Report
Richard A. Rawson, Ph.D., evaluated the reasons why naltrexone (a medication-based treatment for alcohol abuse and dependence and opiate addiction) is not widely used by physicians and practitioners.
April 1, 2004 | Program Result Report
California Health Decisions developed a statewide, pilot education initiative called Healthcare 101: Choosing and Using Prescription Medicines.